Neurocrine Biosciences, Inc. (NASDAQ: NBIX) kicked off on Tuesday, up 0.95% from the previous trading day, before settling in for the closing price of $131.74. Over the past 52 weeks, NBIX has traded in a range of $89.04-$148.37.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 34.77%. While this was happening, its average annual earnings per share was recorded 104.29%. With a float of $96.92 million, this company’s outstanding shares have now reached $98.70 million.
Considering the fact that the conglomerate employs 1400 people, you should pay attention to its efficiency factor.
Neurocrine Biosciences, Inc. (NBIX) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Neurocrine Biosciences, Inc. is 2.60%, while institutional ownership is 92.53%. The most recent insider transaction that took place on Apr 01 ’24, was worth 37,346. In this transaction Chief Regulatory Officer of this company sold 272 shares at a rate of $137.30, taking the stock ownership to the 7,507 shares. Before that another transaction happened on Mar 21 ’24, when Company’s Chief Regulatory Officer sold 5,000 for $145.06, making the entire transaction worth $725,320. This insider now owns 7,507 shares in total.
Neurocrine Biosciences, Inc. (NBIX) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 14.65 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 104.29% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 18.00% during the next five years compared to 62.04% growth over the previous five years of trading.
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) Trading Performance Indicators
Take a look at Neurocrine Biosciences, Inc.’s (NBIX) current performance indicators. Last quarter, stock had a quick ratio of 2.40. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.01. Likewise, its price to free cash flow for the trailing twelve months is 36.60.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 2.43, a number that is poised to hit 1.07 in the next quarter and is forecasted to reach 6.86 in one year’s time.
Technical Analysis of Neurocrine Biosciences, Inc. (NBIX)
Compared to the last year’s volume of 0.85 million, its volume of 0.77 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 5.91%. Additionally, its Average True Range was 3.92.
During the past 100 days, Neurocrine Biosciences, Inc.’s (NBIX) raw stochastic average was set at 61.30%, which indicates a significant increase from 14.62% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 21.77% in the past 14 days, which was lower than the 24.35% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $136.54, while its 200-day Moving Average is $119.78. Nevertheless, the first resistance level for the watch stands at $134.95 in the near term. At $136.91, the stock is likely to face the second major resistance level. The third major resistance level sits at $138.64. If the price goes on to break the first support level at $131.26, it is likely to go to the next support level at $129.53. Should the price break the second support level, the third support level stands at $127.57.
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) Key Stats
The company with the Market Capitalisation of 13.23 billion has total of 99,507K Shares Outstanding. Its annual sales at the moment are 1,887 M in contrast with the sum of 249,700 K annual income. Company’s last quarter sales were recorded 515,200 K and last quarter income was 147,700 K.
